NM-3

· Genzyme, a Sanofi Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NM-3, covering 2015-05-20 to 2015-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors. [Phase 1]